Karyopharm Therapeutics
KPTI
KPTI
71 hedge funds and large institutions have $587M invested in Karyopharm Therapeutics in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $704M → $587M (-$117M)
32% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 22
Holders
71
Holding in Top 10
2
Calls
$1.99M
Puts
$2.21M
Top Buyers
| 1 | +$22.5M | |
| 2 | +$16.2M | |
| 3 | +$13.9M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$7.68M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$6.19M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$6.98M | |
| 3 | -$3.67M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.49M |
| 5 |
PA
Perceptive Advisors
New York
|
-$2.13M |